Carregant...

Endothelin‐1 contributes to maintenance of systemic but not portal haemodynamics in patients with early cirrhosis: a randomised controlled trial

BACKGROUND AND AIMS: Increased endothelin (ET)‐1 activity may contribute to the complications of cirrhosis and portal hypertension. The aim of this study was to assess the systemic and portal haemodynamic effects of selective ET‐A and ET‐B receptor antagonism in patients with cirrhosis. METHODS: Six...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Tripathi, D, Therapondos, G, Ferguson, J W, Newby, D E, Webb, D J, Hayes, P C
Format: Artigo
Idioma:Inglês
Publicat: BMJ Group 2006
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1860020/
https://ncbi.nlm.nih.gov/pubmed/16434427
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.2005.077453
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!